HOME > VC DEALS > Pathos AI, Inc.
Deal IconDeal

Pathos AI, Inc.

Pathos AI raises $237M Series E

Pathos AI, Inc., a New York City-based AI drug discovery company, raised $237 million in a Series E fundraising round led by Bristol Myers Squibb.

More on STAT+ →


Similar AI deals

The VC Industry's trusted resource

Stay informed on industry shifts, deal trends, and career opportunities in venture capital.

Jobs